Sponsored Links
| No Cancer Risk With Angiotensin Receptor Blockers |
 |
 |
 |
| Medical News - Hypertension | |||
|
Angiotensin receptor blockers (ARBs) do not increase cancer risk, the FDA reported, after investigating the blood pressure medications following a study last year suggesting there might be a small risk. The FDA's (Food and Drug Administration's) one-year safety review reported that it found no evidence of an increased risk of cancer in over 155,000 patients in 31 randomized clinical trials... Read more: Hypertension News From Medical News Today
|